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6.3 Hepatic Resections for Metastatic Tumors 
s. Iwatsuki and T. E. Starzl 
The most common malignant neoplasm of the liver 
by far is metastatic tumor. Edmonson and Peters 
(1982) reported that among 7299 autopsies of 
extrahepatic primary malignancies. 38 % of them 
had metastases to the liver, and they found that the 
five most common primary malignancies which had 
spread to the liver were bronchogenic, colonic, 
pancreatic, mammary and gastric cancer. 
Although hepatic metastasis is a common 
event in the course of various malignant neoplasms, 
hepatic resection is uncommon. By the time the 
hepatic metastases are found, malignant tumors 
have usually already spread to extrahepatic sites. 
As an example, only 5-10% of patients who 
developed hepatic metastasis from colorectal can-
cer are candidates for hepatic resection, which 
comprises the largest number of patients for this 
operation (Wagner et al. 1984, Wood et al. 1976). As 
a rule, once hepatic metastasis is established, the 
disease is far advanced and the prognosis is ex-
tremely poor. 
Over the years the authors have treated 118 
patients with hepatic metastases of various malig-
. nant neoplasms by hepatic resection. The expe-
rience is summarized in this chapter. 
Case Materials and Methods 
Over the last 20 years, a total of 400 patients have 
been treated by subtotal hepatic resection at our 
institution. 108 of these patients received surgery at 
the University of Colorado Health Sciences Center 
before 1981, and since 1981 the remaining 292 
patients were operated upon at the University 
Health Center of Pittsburgh. 181 patients had 
histologically benign hepatic lesions and the re-
maining 219 patients had histologically malignant 
hepatic neoplasms. Of the 219 hepatic malig-
nancies. 101 were primary hepatic malignancies 
and 118 were metastatic tumors (Table 6.3.1). 
The most common metastatic tumor treated 
by hepatic resection was colorectal cancer (86 
patients), followed by adrenal cancer and renal 
cancer (5 patients each) and by carcinoid tumor. 
breast cancer and leiomyosarcoma (4 patients 
Table 6.3.1 Indications of 400 hepatic resections 
Primary hepatic malignancy 
Secondary hepatic malignancy 
Histologically benign hepatic lesion 
101 patients 
118 patients 
181 patients 
Table 6.3.2 Histology of 118 secondary hepatic 
malignancies 
No. of patients 
Colorectal cancer 86 
Adrenal cancer 5 
Renal cancer 5 
~~M~~~r 4 
Breast cancer 4 
Leiomyosarcoma of GI tract 4 
Ovarian cancer 2 
Melanoma 2 
Glycagonoma (pancreas) 1 
Squamous cell cancer of cervix 1 
Medullary carcinoma of thyroid 1 
Spindle cell sarcoma of intestine 1 
Endometrial sarcoma of uterus 1 
Ewing's sarcoma 1 
Total 118 
each). The origins of all metastatic hepatic malig-
nancies are listed in Table 6.3.2. 
The survival rates were calculated as of No-
vember 15, 1987 by the Kaplan-Meier method. 
Statistical comparisons were made by the Breslow 
and Mantel-Cox methods. The difference was 
considered as significant when the p value was less 
than 0.05. 
Our operative techniques have been described 
in detail elsewhere (Starzl et al. 1975, 1980. 1982). 
The extent of hepatic resections was classified into 
the following six types: right and left trisegment-
ectomy. right and left lobectomy, left lateral seg-
mentectomy, and non-anatomical local excision or 
wedge resection. Right trisegmentectomy is the 
removal of the entire right lobe plus the medial 
segment of the left lobe. Extended right lobectomy. 
which removes a part of the medial segment with 
the right lobe. was classified as right lobectomy in 
this report. Left trisegmentectomy is the removal of 
the entire left lobe plus the anterior segment of the 
right lobe. Extended left lobectomy was classified as 
left lobectomy. The extent of resection by various 
techniques is depicted in Figure 6.3.1. 
Results 
Operative Mortality 
All deaths within a month of hepatic resection were 
counted as operative deaths. There was, however. 
no operative death for metastatic liver tumors 
after 40 right trisegmentectomies, 5 left trisegment-
ectomies, 38 right lobectomies, 16 left lobectomies, 
. ,.:...'.... .. D~KI ~ ,-' -'. ~ -," ~-"KIKKK . , ,. . ~ . ~K . 
/fflftflilll~DKr!DllfwiiR_miiiiimiiit~¥?oiKiiiiwmiiiiiiiiiripDiiKi!rtria·~feriTiflDTjf"iii·iiiiiii-Kd"f_riii-ii;j·friii"ti1iiiiir __ x~D~sii·iSivmii·iiiiii;;DsKii;iiitfiiipiirii:yrt~I%F:;diiiwiiii-1fiiieiiwii-q:illllDf!rC_~*"ijiD iil*iii·;:-:-::K;;;;r;jlfKiiww_rK;:-:~·:ioyl%ool--:f;ri:lKll*"·oi<i-;Etr ... -C.' ... ' ..... __ kl ... IoiU ___ a.a .. '4l 
1111' 
1D"~!11 
, .Ii t 
192 6 Surgical Management of Malignant Tumors of the Liver 
LATERAL SEGMENTECTOMY NON-ANATOMICAL RESECTION survival rates of patients with hepatic metastases 
LEFT LOBECTOMY RIGHT LOBECTOMY 
LT, TRISEGMENTECTOMY RT. TRISEGMENTECTOMY 
Fig,6.3,1 Six kinds of hepatic resection 
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Fig.6.3,2 Actuarial survival rates of 118 patients with 
various hepatic metastases after hepatic resection 
12 left lateral segmentectomies and 7 non-anatom-
ical, wedge resections. The operative mortality was 
zero percent after 118 liver resections. 
Survival Rates 
The overall survival rates of 118 patients with 
metastatic liver tumors were 86 % at 1 year, 63 % at 
2 years, 46 % at 3 years, 36 % at 4 years and 31 % at 
5 years after hepatic resection (Figure 6.3.2). The 
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from colorectal cancer were significantly higher 
than those of patients with metastases from malig-
nancies other than colorectal cancer (p less than 
0.05), as shown in Figure 6.3.3. 1-5 year survival 
rates of the former were 90 %, 70 %, 50 %, 38 % 
and 38 %, respectively, and those of the latter were 
73%,42%,33%,28% and 16%, respectively. 
Causes of Death 
A total of 56 deaths were confirmed as of November 
t 5, 1987. All but two patients died with recurrence 
of malignant tumors. One of the two patients died 
suddenly at home in the second postoperative 
month, and another patient died from liver failure 
in the third month. The majority of the recurrences 
were intra-abdominal, inside and outside the re-
maining liver, followed by lung, bone and brain 
metastases. 
Fiw-Year Sunivors 
Among the 36 patients who had had hepatic 
resection more than 5 years ago, 11 patients lived 
more than 5 years (actual 5-year survival rate of 
31 %). 9 of the II patien ts had had hepa tic resection 
for metastatic colorcctal cancer, one patient having 
metastasis from neuroblastoma of the right adrenal 
gland and another patient having metastatic carcin-
oid tumor of the ileum. 3 of the 5-year survivors had 
had right trisegmentectomy, 3 had had right lobec-
tomy, and 4 had had left lateral segmentectomy. 
Discussion 
None of the 118 patients with hepatic metastases 
died within a month after hepatic resection. but 8 of 
the 101 patients with primary hepatic malignancy 
and 4 of the 101 patients with histologically benign 
hepatic lesions dies \\ ithin a month of the operation 
(Table 6.3.3).5 of the 8 deaths among patients with 
primary hepatic malignancy occurred in the pa-
tients with cirrhosis. :2 of the 4 deaths among 
patients \\ilh histologically benign lesions occurred 
in hepatic trauma. one in fungal abscess, and 
another in misdiagnosed hepatoma in the cirrhotic 
liver. 8 of the 12 operative deaths were after 
trisegmentectomies, 3 were after right lobectomy 
and one after a wedge resection. The operative 
mortality rate of 3 % (12 out of 400 patients) in our 
series and those of others (Fortner et al. 1981, Lin et 
al. 1987, Thompson et al. 1983, Tsuzuki et al. 1984) 
clearly indicates that hepatic resection can now be 
performed quite safely if the liver is not cirrhotic. 
The lower operative mortality among patients with 
metastatic tumors in our series and those of others 
(Adson et al. 1987, August et al. 1985, Fortner et al. 
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Fig.6.3.3 Actuarial survival rates of 86 patients 
with hepatic metastases from colorectal cancer 
were significantly better than those of 32 pa-
tients with metastases from other than 
colorectal cancer after hepatic resection. Solid 
line: colorectal cancer; broken line: others 
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(86) -- COLORECTAL CANCER (n = 86) 
--- OTHERS (n = 32) 
(9) 
Table 6.3.3 Operative mortality (deaths within a month) 
Right Left Right 
triseg- triseg- Lobectomy 
mentectomy mentectomy 
Primary 
malignancy 4 of 47 2 of 8 1 of 16 
Secondary 
malignancy o of 40 o of 5 o of 38 
Benign 
Lesion 2 of 32 o of 2 2 of 55 
Total 6 of 119 2 of 15 3 of 109 
1984, N ordlinger et al. 1987) may reflect the fact 
that the remaining part of the liver is usually normal 
in secondary hepatic malignancy. 
The survival rates after hepatic resection for 
metastatic colorectal cancer in this report (90 % at 1 
year. 50 E~/o at 3 years. and 38 % at 5 years) are 
slightly better than those obtained by others (Starzl 
etaI.1975.1980.1982. ThompsonetaI.1983). but 
the differences are probably not statistically signifi-
cant. In our first report (Iwatsuki et al. 1983) the 5-
year actuarial survival rate was 57 %, and in the 
second report (lwatsuki et a\. 1986) it was 46 % In 
this report. the 5-year actuarial survival rate has 
decreased further to 38 %. and the 5-year actual 
survival rate was 31 %. This decline in the survival 
rate is mainly due to the method of survival 
calculation (the method of Kaplan-Meier), but is 
also due to the fact that more advanced lesions were 
resected by trisegmentectomies during the last 5 
years. The prognosis for metastatic lesions requir-
ing trisegmentectomies was much worse than that 
of lesions which required lobectomies and lesser 
resections (I watsuki et al. 1986). 
Median survival rates of patients who had had 
unresected solitary and multiple unilobar lesions 
Left Left 
Lobectomy lateral Seg- Local Excision Total 
mentectomy 
o of 17 o of 3 1 of 10 8 of 101 
o of 16 o of 12 o of 7 o of 118 
o of 14 o of 8 o of 70 4 of 181 
o of 47 o of 23 1 of 87 12 of 400 
were 21 and 15 months. respectively. according to 
the report from the Mayo Clinic (Edmondson and 
Peters 1982). In our experience. the median survival 
rate for unilobar lesions, the lesions which were 
removed by lobectomy or lesser resection. was more 
than 48 months. while that for bilobar lesions, the 
lesions which required trisegmentectomies. was 
more than 24 months (Wagner et al. 1984). This 
improved survival rate by hepatic resection clearly 
justifies our efforts whenever possible to remove all 
hepatic metastases from colorectal cancer. 
Isolated hepatic metastases from malignant 
tumors other than colorectal cancer are rare. and 
the experience in hepatic resection for these non-
colorectal metastases is quite limited. Our personal 
group of 32 such patients is the largest in the 
literature to our knowledge. A larger collection can 
only be found in the multi-institutional review by 
Foster (1978). Although it may not be meaningful 
to consider all metastases from various primary 
malignancies as a group, the survival rates after 
hepatic resection of metastases from non-colorectal 
cancer were significantly worse than those of 
colorectal cancer, as shown in Figure 6.3.3. The 
median survival rate of this group was 20 months. 
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However, 7 patients survived more than 3 years 
after hepatic resection; one patient with neuro-
blastoma of the adrenal gland and one patient with 
carcinoid tumor lived more than 7 years, one 
patient with leiomyosarcoma of the rectum, one 
patient with medullary carcinoma of the thyroid 
and endometrial sarcoma of the uterus lived more 
than 4 years, and one patient with leiomyosarcoma 
of the stomach and one patient with adenocarci-
noma of the ovary lived more than 3 years. 
In Foster's collective review (1978),9 (13 %) of 
the 69 patients died postoperatively, but 19 patients 
lived more than 2 years, 8 of whom lived more than 
5 years. Half of these long-term survivors had 
Wilms' tumor. The median survival rate for Wilms' 
tumor was 24 months, but that of other malig-
nancies, such as melanoma, leiomyosarcoma, and 
cancers of the pancreas, stomach, uterus, ovary, 
kidney and breast, was less than t 2 months. Based 
on these data, Foster concluded, 10 years ago, that 
hepatic resection of metastases from non-colorectal 
cancer should be discouraged. We have been in 
disagreement with his conclusion. In our experience 
there was no operative mortality after hepatic 
resection of metastatic tumors, and three-quarters 
of these patients were expected to live more than 
one year. It is unfortunate that the physical and 
psychological palliation achieved by this aggressive 
but safe operative approach cannot be expressed 
numerically. We will continue in our efforts to 
remove these otherwise untreatable malignant 
lesions surgically until a safer and more effective 
therapy can be established. 
It is quite discouraging, though, to realize that 
nearly all of the deaths after successful removal of 
hepatic metastasis were caused directly or indirectly 
by recurrence of the primary malignancy. The 
recurrence most frequently occurred during the first 
couple of years after hepatic resection, but also 
recurred even after 5 years. There was usually 
enough time for adjuvant therapy. As major hepat-
ic resection can now be performed with a minimum 
of risk, safer and more effective adjuvant chemo-
therapy and immunotherapy must be developed for 
further improvement in survival rales. 
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